Citation

Park EM, Rosenstein DL. Dialogues Clin. Neurosci. 2015; 17(2): 171-180.

Affiliation

Department of Psychiatry and Department of Medicine University of North Carolina, Chapel Hill, North Carolina, USA.

Copyright

(Copyright © 2015, Les Laboratoires Servier)

DOI

unavailable

PMID

26246791

PMCID

PMC4518700

Abstract

Adolescents and young adults (AYAs) with cancer are at risk for depression due to disruptions in their developmental trajectory, greater physical symptom burden, and increased likelihood of developing aggressive disease. Rates of depression and other psychological disorders are substantially higher in AYAs with cancer when compared with older adults. Psychiatrists caring for these patients must consider the age-appropriate developmental context of these patients along with familial and medical factors that may influence the presentation and treatment of depression. Previous research suggests that psychosocial interventions specifically designed for AYA patients are promising, but studies of psychopharmacology treatments for depression are lacking. There is a pressing need for prospective studies and controlled clinical trials that evaluate the optimal strategies for treating depression in this patient group.

Language: en